HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [HBA2: c.269A>T (or HBA1)] and α-Thalassemia: A Clinical Update.

Abstract
A female proband homozygous for both Hb Luton [α89(FG1)His→Leu (CAC>CTC), HBA2: c.269A>T (or HBA1)], a high oxygen affinity hemoglobin (Hb), and for α(+)-thalassemia (α-thal), (-α(4.2), leftward deletion) was first described in 2012. This is a follow-up report of the same case. At the age of 18, the described patient presented with progressively worsening lethargy, headaches, dizziness, syncope and Raynaud's phenomenon. Following extensive cardiological and neurological investigation, it was felt that significant erythrocytosis was the most likely cause. Venesection followed by regular exchange transfusions were arranged with marked amelioration in symptomatology. In the vast majority of cases of high oxygen affinity Hbs, venesection is not recommended due to the asymptomatic phenotype and reduced oxygen delivery resulting from venesection. This update describes the evolving phenotype of this unique proband and, to the best of our knowledge, the first use of regular, long-term therapeutic red cell exchange transfusions in a case of high affinity Hb.
AuthorsAmelia Oliveira, Dana Warcel, Nancy Huntley, Perla Eleftheriou, John B Porter
JournalHemoglobin (Hemoglobin) Vol. 40 Issue 2 Pg. 127-9 ( 2016) ISSN: 1532-432X [Electronic] England
PMID26852627 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Codon
  • Hemoglobins, Abnormal
  • hemoglobin Luton
Topics
  • Adolescent
  • Alleles
  • Codon
  • Female
  • Hemoglobins, Abnormal (genetics)
  • Homozygote
  • Humans
  • Mutation
  • Phenotype
  • Polycythemia (diagnosis, genetics)
  • alpha-Thalassemia (diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: